HUP9900120A3 - Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them - Google Patents
Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing themInfo
- Publication number
- HUP9900120A3 HUP9900120A3 HU9900120A HUP9900120A HUP9900120A3 HU P9900120 A3 HUP9900120 A3 HU P9900120A3 HU 9900120 A HU9900120 A HU 9900120A HU P9900120 A HUP9900120 A HU P9900120A HU P9900120 A3 HUP9900120 A3 HU P9900120A3
- Authority
- HU
- Hungary
- Prior art keywords
- producing
- pharmaceutical compositions
- compositions containing
- benzosulfone
- derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98100690 | 1998-01-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9900120D0 HU9900120D0 (en) | 1999-03-29 |
HUP9900120A2 HUP9900120A2 (hu) | 1999-11-29 |
HUP9900120A3 true HUP9900120A3 (en) | 2001-02-28 |
Family
ID=8231273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9900120A HUP9900120A3 (en) | 1998-01-16 | 1999-01-15 | Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them |
Country Status (34)
Country | Link |
---|---|
US (1) | US5990105A (hu) |
EP (1) | EP0930302B1 (hu) |
JP (1) | JP3249092B2 (hu) |
KR (1) | KR100319250B1 (hu) |
CN (1) | CN1148356C (hu) |
AR (1) | AR014313A1 (hu) |
AT (1) | ATE236136T1 (hu) |
AU (1) | AU757841B2 (hu) |
BR (1) | BR9900065A (hu) |
CA (1) | CA2258454A1 (hu) |
CO (1) | CO5090847A1 (hu) |
CZ (1) | CZ12099A3 (hu) |
DE (1) | DE69906397T2 (hu) |
DK (1) | DK0930302T3 (hu) |
ES (1) | ES2193607T3 (hu) |
HK (1) | HK1022310A1 (hu) |
HR (1) | HRP990011B1 (hu) |
HU (1) | HUP9900120A3 (hu) |
ID (1) | ID23234A (hu) |
IL (1) | IL128027A (hu) |
MA (1) | MA26599A1 (hu) |
MY (1) | MY121778A (hu) |
NO (1) | NO312065B1 (hu) |
NZ (1) | NZ333706A (hu) |
PE (1) | PE20000170A1 (hu) |
PL (1) | PL194735B1 (hu) |
PT (1) | PT930302E (hu) |
RU (1) | RU2201922C2 (hu) |
SG (1) | SG71898A1 (hu) |
SI (1) | SI0930302T1 (hu) |
TR (1) | TR199900090A3 (hu) |
TW (1) | TW553938B (hu) |
YU (1) | YU1199A (hu) |
ZA (1) | ZA99254B (hu) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7030109B2 (en) | 1999-07-19 | 2006-04-18 | Pharmacia & Upjohn Company | 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
MY122278A (en) * | 1999-07-19 | 2006-04-29 | Upjohn Co | 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
DE19956791A1 (de) * | 1999-11-25 | 2001-05-31 | Merck Patent Gmbh | Neue Sulfonyloxazolamine |
US7034029B2 (en) | 2000-11-02 | 2006-04-25 | Wyeth | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
AU2002220051B2 (en) * | 2000-11-02 | 2007-05-24 | Wyeth | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
RU2268884C2 (ru) | 2001-08-10 | 2006-01-27 | Ф.Хоффманн-Ля Рош Аг | Арилсульфонильные производные, обладающие сродством к рецептору 5-ht6, и способ их получения |
WO2003030901A1 (en) * | 2001-10-09 | 2003-04-17 | Pharmacia & Upjohn Company | Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands |
ATE398108T1 (de) * | 2002-03-27 | 2008-07-15 | Glaxo Group Ltd | Chinolinderivate und deren verwendung als 5-ht6 liganden |
US6875771B2 (en) | 2002-07-26 | 2005-04-05 | Bristol-Myers Squibb Company | Pyridopyrimidine derivatives as 5-HT6 antagonists |
ES2375111T3 (es) * | 2002-11-21 | 2012-02-24 | Novartis Ag | Pirimidinas 2,4,6-trisustituidas como inhibidores de fosfotidilinositol (pi) 3-quinasa y su uso en el tratamiento de c�?ncer. |
GB0305575D0 (en) | 2003-03-11 | 2003-04-16 | Glaxo Group Ltd | Novel compounds |
GB0419192D0 (en) * | 2004-08-27 | 2004-09-29 | Merck Sharp & Dohme | Therapeutic agents |
WO2006066790A1 (en) * | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
EP1877381A1 (en) * | 2005-05-04 | 2008-01-16 | Vertex Pharmaceuticals Incorporated | Pyridines useful as modulators of ion channels |
JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
AR061481A1 (es) | 2006-06-16 | 2008-08-27 | Lundbeck & Co As H | Compuestos con actividad combinada sobre sert, 5-ht3 y 5-ht1a |
KR20090079259A (ko) * | 2006-11-09 | 2009-07-21 | 에프. 호프만-라 로슈 아게 | 5-ht6 억제제로서 아릴설폰일 피롤리딘 |
WO2008098058A1 (en) * | 2007-02-06 | 2008-08-14 | Novartis Ag | Pi 3-kinase inhibitors and methods of their use |
ES2370680T3 (es) * | 2007-10-26 | 2011-12-21 | Suven Life Sciences Limited | Compuestos de aminoarilsulfonamida y su empleo como ligandos de 5-ht6. |
US20110034565A1 (en) | 2008-04-18 | 2011-02-10 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
UA100192C2 (en) | 2008-11-11 | 2012-11-26 | УАЙТ ЭлЭлСи | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
RU2443697C1 (ru) | 2010-12-21 | 2012-02-27 | Александр Васильевич Иващенко | Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения |
MX342326B (es) | 2011-09-27 | 2016-09-26 | Novartis Ag | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante. |
UY34632A (es) | 2012-02-24 | 2013-05-31 | Novartis Ag | Compuestos de oxazolidin- 2- ona y usos de los mismos |
US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
RS58174B1 (sr) | 2013-01-18 | 2019-03-29 | Cardioxyl Pharmaceuticals Inc | Farmaceutske kompozicije koje sadrže donore nitroksila |
JP6387360B2 (ja) | 2013-03-14 | 2018-09-05 | ノバルティス アーゲー | 変異idhの阻害薬としての3−ピリミジン−4−イル−オキサゾリジン−2−オン |
US9663498B2 (en) | 2013-12-20 | 2017-05-30 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
GB201514021D0 (en) * | 2015-08-07 | 2015-09-23 | Arner Elias Set Jeno | Novel Pyridines and their use in the treatment of cancer |
US11028067B2 (en) | 2017-02-07 | 2021-06-08 | Oblique Therapeutics Ab | Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer |
WO2018146468A1 (en) | 2017-02-07 | 2018-08-16 | Oblique Therapeutics Ab | Sulfinylpyridines and their use in the treatment of cancer |
CN110382464A (zh) | 2017-02-07 | 2019-10-25 | 欧比力克治疗公司 | 烃基磺酰基取代的吡啶和其在癌症治疗中的用途 |
CN110382480A (zh) | 2017-02-07 | 2019-10-25 | 欧比力克治疗公司 | 杂环基磺酰基取代的吡啶和其在癌症治疗中的用途 |
JP7268049B2 (ja) | 2018-03-08 | 2023-05-02 | インサイト・コーポレイション | PI3K-γ阻害剤としてのアミノピラジンジオール化合物 |
WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55151560A (en) * | 1979-05-14 | 1980-11-26 | Ishihara Sangyo Kaisha Ltd | Pyridylthioaniline compound |
JPS60185764A (ja) * | 1984-03-05 | 1985-09-21 | Wako Pure Chem Ind Ltd | ピリジン誘導体の新規な製造法 |
DE4137433A1 (de) * | 1990-11-27 | 1992-06-11 | Merck Patent Gmbh | 3,6-disubstituierte-2-halogenpyridine |
GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
JPH06127956A (ja) * | 1992-10-16 | 1994-05-10 | Copal Co Ltd | ガラスレンズの成形装置 |
JP3907722B2 (ja) * | 1995-08-23 | 2007-04-18 | 株式会社クラレ | 2−ヒドロキシピリジン類および/または2(1h)−ピリドン類の製造法 |
JP3907721B2 (ja) * | 1995-08-23 | 2007-04-18 | 株式会社クラレ | 2−アラルキルオキシピリジン類の製造法 |
EP0894791A4 (en) * | 1996-03-29 | 2001-07-11 | Ube Industries | PYRIMIDINE COMPOUNDS, PROCESS FOR THE PRODUCTION THEREOF AND BACTERICIDES FOR AGRICULTURE AND HORTICULTURE |
JP3814885B2 (ja) * | 1996-09-03 | 2006-08-30 | 宇部興産株式会社 | 2−シアノピリミジン誘導体、その製造法及び農園芸用の殺菌剤 |
WO1998054139A1 (de) * | 1997-05-30 | 1998-12-03 | Basf Aktiengesellschaft | Verfahren zur herstellung substituierter thiopyridine |
KR100396431B1 (ko) * | 1998-01-26 | 2003-09-02 | 가부시키가이샤 구라레 | 2-술포닐피리딘 유도체 및 2-[((2-피리딜)메틸)티오]-1h-벤즈이 |
-
1999
- 1999-01-08 AT AT99100149T patent/ATE236136T1/de not_active IP Right Cessation
- 1999-01-08 SI SI9930252T patent/SI0930302T1/xx unknown
- 1999-01-08 DK DK99100149T patent/DK0930302T3/da active
- 1999-01-08 DE DE69906397T patent/DE69906397T2/de not_active Expired - Fee Related
- 1999-01-08 EP EP99100149A patent/EP0930302B1/en not_active Expired - Lifetime
- 1999-01-08 ES ES99100149T patent/ES2193607T3/es not_active Expired - Lifetime
- 1999-01-08 PT PT99100149T patent/PT930302E/pt unknown
- 1999-01-12 PE PE1999000027A patent/PE20000170A1/es not_active Application Discontinuation
- 1999-01-12 NZ NZ333706A patent/NZ333706A/xx unknown
- 1999-01-13 KR KR1019990000667A patent/KR100319250B1/ko not_active IP Right Cessation
- 1999-01-13 TW TW088100465A patent/TW553938B/zh not_active IP Right Cessation
- 1999-01-13 SG SG1999000077A patent/SG71898A1/en unknown
- 1999-01-13 YU YU1199A patent/YU1199A/sh unknown
- 1999-01-13 CA CA002258454A patent/CA2258454A1/en not_active Abandoned
- 1999-01-13 HR HR98100690.1 patent/HRP990011B1/xx not_active IP Right Cessation
- 1999-01-13 IL IL12802799A patent/IL128027A/en unknown
- 1999-01-14 ZA ZA9900254A patent/ZA99254B/xx unknown
- 1999-01-14 TR TR1999/00090A patent/TR199900090A3/tr unknown
- 1999-01-14 CZ CZ99120A patent/CZ12099A3/cs unknown
- 1999-01-14 JP JP00741099A patent/JP3249092B2/ja not_active Expired - Fee Related
- 1999-01-14 PL PL330841A patent/PL194735B1/pl not_active IP Right Cessation
- 1999-01-14 BR BR9900065-2A patent/BR9900065A/pt not_active Application Discontinuation
- 1999-01-14 CO CO99001735A patent/CO5090847A1/es unknown
- 1999-01-14 MY MYPI99000139A patent/MY121778A/en unknown
- 1999-01-15 AU AU12110/99A patent/AU757841B2/en not_active Ceased
- 1999-01-15 MA MA25434A patent/MA26599A1/fr unknown
- 1999-01-15 NO NO19990187A patent/NO312065B1/no unknown
- 1999-01-15 CN CNB99100955XA patent/CN1148356C/zh not_active Expired - Fee Related
- 1999-01-15 US US09/232,775 patent/US5990105A/en not_active Expired - Fee Related
- 1999-01-15 AR ARP990100132A patent/AR014313A1/es unknown
- 1999-01-15 HU HU9900120A patent/HUP9900120A3/hu unknown
- 1999-01-15 ID IDP990038D patent/ID23234A/id unknown
- 1999-01-15 RU RU99101350/04A patent/RU2201922C2/ru not_active IP Right Cessation
-
2000
- 2000-02-28 HK HK00101191A patent/HK1022310A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9900120A3 (en) | Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0000748A2 (en) | 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0102084A3 (en) | Quinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0103224A3 (en) | Quinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0003141A3 (en) | 4-phenylpiperidine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0100723A3 (en) | Indole derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0002893A3 (en) | Substituted quinazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9802422A3 (en) | Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9904521A3 (en) | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9802653A3 (en) | Substituted imidazolidine derivatives, process for producing them, and pharmaceutical compositions containing them | |
HUP0003608A3 (en) | Tetrahydroisoquinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9901739A3 (en) | Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them | |
HUP0003267A3 (en) | Heteroaryl derivatives, pharmaceutical compositions containing them and process for producing them | |
HUP0102622A3 (en) | Biphenyl derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9802121A3 (en) | Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HK1039122A1 (zh) | 取代的6-苄基-4-氧代嘧啶,其製備方法以及含該化合物的藥物組合物 | |
HUP9801423A3 (en) | Chromene derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0105479A3 (en) | Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0003148A2 (en) | Cyanoguanidine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0103316A3 (en) | 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use | |
HUP0003150A2 (en) | Cyanoguanidine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0100785A3 (en) | Indole derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0101234A3 (en) | Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof | |
HUP0100432A3 (en) | Pyridyle derivatives as antivirals, process for producing them and pharmaceutical compositions containing them | |
HUP0202379A3 (en) | New compounds, process for producing them and pharmaceutical compositions containing them |